F. Hoffmann-La Roche AG, commonly known as Roche, ranked first on the list of the largest biotech companies in Switzerland. It is a Swiss global healthcare firm with two divisions: pharmaceuticals and diagnostics. The company's headquarters are in Basel. Roche is the world's fifth-largest pharmaceutical firm by sales and the world's top provider of cancer therapies.

The business owns 100% of the American biotechnology company Genentech, as well as the Japanese biotechnology company Chugai Pharmaceuticals and the US-based subsidiaries Ventana and Foundation Medicine. Roche Diagnostics offers diagnostic equipment and reagents for use in research and medical diagnostics. Roche Applied Science, Roche Professional Diagnostics, Roche Diabetes Care, Roche Molecular Diagnostics, and Roche Tissue Diagnostics (Ventana) are the five primary business sectors. Roche Professional Diagnostics' headquarters are in Rotkreuz, Switzerland.

Except for Roche Applied Science, all business areas are focused on healthcare applications, targeting physicians, hospitals and clinics, and consumers. Applied Science focuses on academic research as well as the pharmaceutical and biotechnology businesses.

Founded: 1896
Headquarters: Basel, Switzerland
Website: https://www.roche.com/

Visit website

Novartis is a Swiss multinational pharmaceutical firm with headquarters in Basel, Switzerland, and global research in Cambridge, Massachusetts, USA. Novartis is one of the world's major pharmaceutical firms in the world. It is striving to get the next generation of medications to patients faster than ever before, from cancer therapies to treatments for the avoidance and management of heart disease.

As a worldwide leader in pharmaceuticals, the company combines cutting-edge research and digital technology to develop transformational therapies in areas with high medical needs. In its search for innovative medications, it always holds the place among the world's top firms spending in research and development.

Novartis drugs reach approximately 800 million people worldwide, and it is constantly looking for novel approaches to expand access to its cutting-edge therapies to more people. Novartis employs around 108,000 people in more than 140 countries worldwide.

Founded: 1996

Headquarters: Basel, Switzerland

Website: https://www.novartis.com/

Visit website

Lonza Group is a Swiss global pharmaceutical, biotechnology, and nutrition manufacturing corporation based in Basel, with main operations in Europe, North America, and South Asia. Lonza was founded in Switzerland in the late nineteenth century. The firm offers product development services to the pharmaceutical and biologic sectors, including customized manufacture of biopharmaceuticals and detection systems, as well as bioscience-related services.

Lonza contributes to #AHealthierWorld by helping its healthcare customers on the path to commercialization. Its 16,000 outstanding employees operate across a worldwide network of more than 30 facilities to serve clients in the pharmaceutical, biotech, and nutrition businesses.

The company helps its clients in developing novel and breakthrough medicines that help treat a wide variety of diseases by combining technological insight with world-class production, scientific understanding, and process excellence. Its best scientific solution is a group of talented individuals working together to develop commitment and ideas that assist customers to help people.

Founded: 1897
Headquarters: Basel, Switzerland
Website: https://www.lonza.com/ Visit website

Bachem is a Swiss biotechnology firm that specializes in chemistry, biochemistry, and pharmaceuticals. It specializes in the commercial production of peptides and complex organic compounds as active medicinal components, the creation of peptide-based biochemicals, and the development of these substances' manufacturing techniques.

With over 50 years of experience and knowledge, Bachem serves pharmaceutical and biotechnology firms worldwide with products for research, clinical development, and commercial application, as well as a broad spectrum of services. Bachem works on a global scale, with headquarters in Switzerland and offices in Europe, the United States, and Asia.

Its medications are used to treat a variety of diseases, including central nervous system problems, metabolic disorders, cancer, and infectious infections. Catalog products and fluorescent dyes are among the company's research products. NCEs, small molecules APIS, and generic APIs are among its active pharmaceutical ingredients.

Founded: 1971

Headquarters: Bubendorf, Switzerland

Website: https://www.bachem.com/

Visit website

Galenica, located in Bern, is a Swiss pharmaceutical and logistics company named after the historical physician Galenus. It was formed in 1927 by 16 pharmacists in Clarens as Collaboration Pharmaceutique SA, a purchasing center for pharmaceutical products.

Galenica is a fully-integrated healthcare provider and is among the largest biotech companies in Switzerland. Galenica manages the largest pharmacy network in Switzerland, with over 500 own, joint venture, and independent partner pharmacies. Galenica also produces and sells well-known own brands and products, exclusive brands and products from business partners, and a wide range of on-site health services and testing to clients. Galenica is also the Swiss healthcare market's largest provider of pre-wholesale and wholesale distribution, as well as database services.

It operates in four divisions: Vifor Pharma, Logistics, Retail, and Healthcare Information. The Vifor Pharma sector operates a fully integrated multinational specialty pharmaceutical firm that investigates, develops, and manufactures its own pharmaceutical products before marketing and distributing them globally. The Logistics division provides pharmaceutical and healthcare firms with product storage and delivery services. The Retail division operates a pharmacy chain under the Amavita and Sun Store brands. The category HealthCare Information provides solutions for the networked healthcare market.

Founded: 1927
Headquarters: Bern, Switzerland
Website: https://www.galenica.com/en/

Visit website

CRISPR Therapeutics is a prominent gene editing firm that uses its unique CRISPR/Cas9 platform to generate transformational gene-based therapies for serious diseases. CRISPR/Cas9 is a revolutionary gene editing technology that enables precise, targeted modifications to genomic DNA. CRISPR Therapeutics is developing a treatment portfolio for a variety of diseases, including hemoglobinopathies, cancer, regenerative medicine, and rare diseases.

CRISPR Therapeutics has formed partnerships with top firms such as Bayer, Vertex Pharmaceuticals, and ViaCyte, Inc. to speed up and expand its operations. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, and has a wholly-owned US subsidiary, CRISPR Therapeutics, Inc., with R&D activities in Cambridge, Massachusetts, as well as business offices in San Francisco, California and London, United Kingdom.

Several drugs are being developed by the company. These include CTX001, a drug being developed in collaboration with Vertex Pharmaceuticals for the treatment of the rare blood disorders Beta thalassemia and sickle cell disease. CTX001 was designated as an orphan medicine by the US Food and Medicine Administration in May 2020 for transfusion-dependent beta-thalassemia and by the European Medicines Agency for sickle cell disease and transfusion-dependent beta-thalassemia.

Founded: 2013
Headquarters: Zug, Switzerland
Website: https://crisprtx.com/

Visit website

Siegfried is a globally known outsourcing partner that offers products and customized services that well fit into a customer's value chain. It's also among the largest biotech companies in Switzerland today. The firm provides a complete variety of services to pharmaceutical sector partners, ranging from drug component development through product development, registration, and production, as well as packaging and transportation.

Siegfried, formerly a fully integrated pharmaceutical business, is now one of the few vendors able to provide both drug component and drug product development and manufacturing abilities. This combination of expertise and experience is unparalleled for a provider of development and manufacturing services.

The company research and produce active pharmaceutical ingredients, related intermediates and controlled substances for pharmaceutical clients with R&D projects. Siegfried also develops and manufactures final dosage forms, including sterile fillings. Approximately 3600 dedicated employees in Switzerland, Germany, France, Spain, Malta, China, and the United States develop innovative and integrated solutions that provide significant added value to its customers.

Founded: 1873

Headquarters: Zofingen, Switzerland

Website: https://www.siegfried.ch/

Visit website

BB Biotech invests in firms in the rapidly increasing biotechnology market and has 30 years of expertise as one of the world's leading investors in this field. It focuses its investments on publicly traded firms that are developing and commercializing innovative pharmaceuticals that provide excellent value to the healthcare system.

BB Biotech strives to offer an average annual double-digit return over the long term, surpassing the general market indexes by a wide margin. BB Biotech invests globally in fast-growing firms that develop and sell novel biotech pharmaceuticals.

BB Biotech has a method of carefully evaluating and selecting biotechnology enterprises with a long-term time horizon and having established products in the marketplace. When making investment decisions, BB Biotech relies on the long-standing experience of its distinguished Board of Directors as well as the investment research skills of Bellevue Asset Management AG's experienced investment management team.

Founded: 1993
Headquarters: Schaffhausen, Switzerland
Website: https://www.bbbiotech.ch/

Visit website

Idorsia is a high-potential biopharmaceutical firm based in Switzerland, a biotech powerhouse of Europe, that specializes in the discovery, development, and commercialization of new small molecules with the goal of expanding the therapeutic options horizon.

The company has more 20-year history of drug discovery, a diverse pipeline of innovative drugs, an experienced team of over 1,300 professionals, and commercial operations in Europe, Japan, and the United States. It offers a diverse and well-balanced portfolio that covers many therapeutic areas. Its portfolio includes two marketed medications as well as more than ten assets in clinical development.

At Idorsia, following the science is forefront approach. It values collaboration with academics, industrial partners, governments, non-governmental organizations (NGOs), and others in order to develop solutions to scientific issues.

Founded: 2017
Headquarters: Allschwil, Switzerland
Website: https://www.idorsia.com/

Visit website

End of the list of the largest biotech companies in Switzerland is HBM Healthcare Investments, it is a venture capital firm located in Switzerland that invests in emerging companies mostly in the biotechnology and human medicine, diagnostics, and medical technology industries. The firm owns and maintains a worldwide portfolio of potential businesses.

The company concentrates on unlisted enterprises, with two-thirds of assets invested in private companies with great potential for earning wealth. As a holding company, it participates in the purchase, disposition, and management of a diverse portfolio, as well as funding and supporting portfolio enterprises as a significant partner. It focuses on firms with products that are either in the advanced stages of development or are currently on the market.

HBM Healthcare is committed to wide diversification based on the following criteria: private and public firms; development phase; therapeutic area; area; and company size (market capitalization and valuation). Western Europe and the United States are the key investment destinations.

Founded: 2001

Headquarters: Zug, Switzerland

Website: https://www.hbmhealthcare.com/en

Visit website